SHERRIKEE CAUSEY: Open Payments
NPI 1649573783 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 11 payments from 7 companies in 2025. Trend: 2023 $960 · 2024 $438 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $304 |
| Axsome Therapeutics, Inc. | 3 | $291 |
| Neurocrine BioSciences, Inc. | 1 | $133 |
| Janssen Pharmaceuticals, Inc | 1 | $125 |
| ABBVIE INC. | 1 | $123 |
| Alkermes, Inc. | 1 | $108 |
| Supernus Pharmaceuticals, Inc. | 1 | $92 |
Products named: FANAPT, Auvelity, INGREZZA, SPRAVATO, VRAYLAR, ARISTADA, Qelbree.
Industry payments across MS — which companies pay providers there.
